PTHL - ftzy.com.cn Value Adjusted for Debt and Cash

Brandmark of ftzy.com.cn (PTHL)

This daily price chart for Pheton Holdings Ltd (PTHL) reflects a business valuation that currently stands at 12.32. Pheton Holdings Ltd has established a unique digital ecosystem for brachytherapy in China, deeply integrating its IT solutions into hospital infrastructure. The asset remains largely insulated from market volatility, as growth depends on the pace of innovation adoption and testing. Revenue is generated through software for the precision calculation of radiation doses.

PTHL (Pheton Holdings Limited) Total Company Value history from 11/23/2025 to 01/16/2026
Brand item of Pheton Holdings

Enterprise Value (EV) combines market capitalization with net debt to determine the total acquisition price of a business. For Pheton Holdings Ltd (PTHL), this metric reflects the actual value of the distribution infrastructure for medtech and Inertia software. By analyzing market value dynamics alongside net debt, investors can discern the impact of B2B contracts on the valuation. Growth in this metric confirms the capitalization of service flows; however, an excessive increase in EV signals the risk of overpaying for the asset.

Competitors of Pheton Holdings Ltd (PTHL)

Aggregate Business Value HLN (Haleon PLC)|Kenvue Corp - Enterprise Value|Value Adjusted for Debt and Cash VRNA (Verona Pharma Inc.)|Jyong Biotech Ltd (MENS) - Total Company Value|LGND (ligand.com) - Total Company Value|Total Company Value Amneal|Perrigo Company PLC - Full Business Value|Enterprise Value ALVO|LQDA (Liquidia Inc.) - Value Adjusted for Debt and Cash|Enterprise Value GLPG (Galapagos NV)|Enterprise Value anipharmaceuticals.com ANIP|MNKD - Total Company Value|Value Adjusted for Debt and Cash AMPH (Amphastar Pharmaceuticals Inc)|Pacira (PCRX) - Total Company Value|Real Price to Acquire Entire Company ARS Corp|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com|Real Price to Acquire Entire Company SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Value Adjusted for Debt and Cash|Total Company Value Tonix Pharmaceuticals Inc. TNXP|SXT Pharmaceuticals (SXTC) - Total Enterprise Value|EPRX: Real Price to Acquire Entire Company|bioharvest.com - Aggregate Business Value|EXOZ: Enterprise Value|Oramed Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|ENTX (Entera Bio Ltd) - Enterprise Value|Total Enterprise Value MindWalk Therapeutics HYFT|Total Company Value ABVC BioPharma (ABVC)|CPIX (cumberlandpharma.com) - Value Adjusted for Debt and Cash|Total Company Value Quantum BioPharma QNTM|FGEN (FibroGen Inc) - Full Business Value|Telomir Pharma - Enterprise Value|Value Adjusted for Debt and Cash RANI (Rani Therapeutics)|SNYR: Enterprise Value|Total Enterprise Value Rallybio (RLYB)|Real Price to Acquire Entire Company LEXX|PULM (Pulmatrix Inc) - Aggregate Business Value|Total Company Value Aptorum Group Limited (APM)|LYRA - Total Enterprise Value|Total Company Value Impact BioMedical IBO|TNFA: Business Value|YCBD: Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash PRFX (PainReform Ltd)|CYTO: Enterprise Value|Lipella Pharma - Value Adjusted for Debt and Cash|Total Company Value OptiNose, Inc.|Total Enterprise Value pieris.com PIRS|Total Company Value Procaps (PROC)|Total Company Value PTPI (Petros Pharmaceuticals Inc)|Enterprise Value QLI (Qilian International Holding Group Limited)|SLRN: Business Value|TFF Pharmaceuticals - Enterprise Value